Overview of Oltan Amlo 40/5
| Property | Description |
|---|---|
| Active ingredients | Amlodipine and Olmesartan Medoxomil |
| Form | Fixed-Dose Combination (FDC) Oral Tablet |
| Pharmacological class | Combination Antihypertensive Agents |
| Common use | Management of Essential Hypertension (High Blood Pressure) |
| Origin | Synthetic |
What Type of Medicine is Oltan Amlo 40/5? (Identity and Classification)
Oltan Amlo 40/5 is a prescription-only, synthetic drug classified as a Combination Antihypertensive Agent for the treatment of essential hypertension. It is formulated as a Fixed-Dose Combination (FDC) oral tablet, integrating two distinct active ingredients into a single pill. The dual-component design is clinically recognized for its effectiveness in adults whose high blood pressure remains inadequately controlled by monotherapy, simplifying the regimen by combining two therapies.
Composition: A Dual-Action Combination of Active Ingredients
The preparation contains Olmesartan Medoxomil (an Angiotensin II Receptor Blocker or ARB) and Amlodipine (a Dihydropyridine Calcium Channel Blocker or CCB). The combination of these two distinct pharmacological classes is deliberately designed to provide complementary therapeutic effects. The Olmesartan component works by blocking signals that cause blood vessels to tighten, while the Amlodipine component acts directly on the vascular walls to induce relaxation.
How the Combination Provides Therapeutic Benefit
The primary purpose is the sustained reduction in blood pressure through a synergistic, dual-action mechanism. This action reduces peripheral vascular resistance, as combining these two agents is more effective at lowering blood pressure than using either drug alone, providing a comprehensive strategy for managing elevated arterial pressure.
Regulatory References

